Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 2
2016 1
2017 3
2018 2
2019 1
2020 4
2021 6
2022 4
2023 5
2024 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Hepatitis D virus interferes with hepatitis B virus RNA production via interferon-dependent and -independent mechanisms.
Lucifora J, Alfaiate D, Pons C, Michelet M, Ramirez R, Fusil F, Amirache F, Rossi A, Legrand AF, Charles E, Vegna S, Farhat R, Rivoire M, Passot G, Gadot N, Testoni B, Bach C, Baumert TF, Hyrina A, Beran RK, Zoulim F, Boonstra A, Büning H, Verrier ER, Cosset FL, Fletcher SP, Salvetti A, Durantel D. Lucifora J, et al. Among authors: alfaiate d. J Hepatol. 2023 May;78(5):958-970. doi: 10.1016/j.jhep.2023.01.005. Epub 2023 Jan 24. J Hepatol. 2023. PMID: 36702177
A review on hepatitis D: From virology to new therapies.
Mentha N, Clément S, Negro F, Alfaiate D. Mentha N, et al. Among authors: alfaiate d. J Adv Res. 2019 Mar 29;17:3-15. doi: 10.1016/j.jare.2019.03.009. eCollection 2019 May. J Adv Res. 2019. PMID: 31193285 Free PMC article. Review.
ANGPTL4 is a potential driver of HCV-induced peripheral insulin resistance.
Gomes D, Sobolewski C, Conzelmann S, Schaer T, Lefai E, Alfaiate D, Tseligka ED, Goossens N, Tapparel C, Negro F, Foti M, Clément S. Gomes D, et al. Among authors: alfaiate d. Sci Rep. 2023 Apr 25;13(1):6767. doi: 10.1038/s41598-023-33728-5. Sci Rep. 2023. PMID: 37185283 Free PMC article.
Treatment with bulevirtide in HIV-infected patients with chronic hepatitis D: ANRS HD EP01 BuleDelta and compassionate cohort.
de Lédinghen V, Fougerou-Leurent C, Le Pabic E, Pol S, Alfaiate D, Lacombe K, Hilleret MN, Lascoux-Combe C, Minello A, Billaud E, Rosa I, Gervais A, Ratziu V, Ganne N, Pageaux GP, Leroy V, Loustaud-Ratti V, Mathurin P, Chas J, Jezequel C, Métivier S, Dumortier J, Arpurt JP, Asselah T, Roche B, Le Gruyer A, Valantin MA, Scholtès C, Gordien E, Tual C, Kortebi A, Coulibaly F, Rosenthal E, Subic-Levrero M, Roulot D, Zoulim F; ANRS HD EP01 BuleDelta study group. de Lédinghen V, et al. Among authors: alfaiate d. JHEP Rep. 2024 Mar 26;6(8):101057. doi: 10.1016/j.jhepr.2024.101057. eCollection 2024 Aug. JHEP Rep. 2024. PMID: 39045338 Free PMC article.
Nucleic acid polymers: much-needed hope for hepatitis D?
Alfaiate D, Negro F. Alfaiate D, et al. Lancet Gastroenterol Hepatol. 2017 Dec;2(12):841-842. doi: 10.1016/S2468-1253(17)30292-3. Epub 2017 Sep 28. Lancet Gastroenterol Hepatol. 2017. PMID: 28964702 No abstract available.
33 results